{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T13:20:48Z","timestamp":1764163248987,"version":"3.46.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital \/ Fimlab Laboratories \/ NordLab","award":["X50060","9N075","X51409","X50070"],"award-info":[{"award-number":["X50060","9N075","X51409","X50070"]}]},{"DOI":"10.13039\/501100006706","name":"Tampereen Tuberkuloosis\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006706","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Survival in bacteremia is influenced by host comorbidities, pathogen virulence, immune response, and the quality of medical care. A deeper understanding of host inflammatory responses may help identify new biomarkers and therapeutic targets to improve outcomes. In this study, we analyzed plasma samples from adult patients with bacteremia who presented to the emergency department. Patients who died within seven days (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200944) were compared to matched survivors (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200944) who lived at least 90 days, with matching based on age, sex, and causative bacterium. Relative concentrations of 92 inflammation-related plasma proteins were measured using the proximity extension assay (Olink Proteomics AB). Of these, 82 proteins were successfully quantified. Thirty proteins, including IL-20RA, CD40, and HGF, were significantly elevated in non-survivors, while three proteins\u2014IFNG, Flt3L, and TNFB\u2014were significantly reduced. Pathway enrichment analysis revealed activation of multiple proinflammatory signaling cascades in non-survivors, particularly those involving IL-6, IL-23, and IL-17. Logistic regression identified HGF, IL-17\u00a0C, and Flt3L as key discriminative proteins between groups. These findings indicate that the host inflammatory profile in bacteremia differs markedly between survivors and early non-survivors. Our results highlight potential diagnostic biomarkers for identifying high-risk patients and point to promising therapeutic targets in the management of bacteremia.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-26183-x","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T13:13:40Z","timestamp":1764162820000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inflammatory response in bacteremia survivors and non-survivors: a case-control study"],"prefix":"10.1038","volume":"15","author":[{"given":"Markus JT","family":"Ojanen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tapio","family":"Seiskari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janne","family":"Aittoniemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heini","family":"Huhtala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reetta","family":"Huttunen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaana","family":"Syrj\u00e4nen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilkka","family":"Junttila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marko","family":"Pesu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7199-6306","authenticated-orcid":false,"given":"Juha","family":"Rannikko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"26183_CR1","doi-asserted-by":"publisher","unstructured":"Lin, J. et al. Risk factors for mortality of bacteremic patients in the emergency department. Acad. Emerg. Med. 16 (8), 749\u2013755. https:\/\/doi.org\/10.1111\/j.1553-2712.2009.00468.x (Aug. 2009).","DOI":"10.1111\/j.1553-2712.2009.00468.x"},{"key":"26183_CR2","doi-asserted-by":"publisher","unstructured":"Blanco, J. et al. Dec., Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study, Crit Care. 12(6) R158. https:\/\/doi.org\/10.1186\/cc7157 (2008).","DOI":"10.1186\/cc7157"},{"key":"26183_CR3","doi-asserted-by":"publisher","unstructured":"Ortega, M. et al. Jun., Epidemiology and outcome of primary community-acquired bacteremia in adult patients, Eur J Clin Microbiol Infect Dis. 26(7), 453\u2013457.  https:\/\/doi.org\/10.1007\/s10096-007-0304-6 (2007).","DOI":"10.1007\/s10096-007-0304-6"},{"issue":"1","key":"26183_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4161\/viru.26514","volume":"5","author":"E Christaki","year":"2014","unstructured":"Christaki, E. & Giamarellos-Bourboulis, E. J. The complex pathogenesis of bacteremia: from antimicrobial clearance mechanisms to the genetic background of the host, Virulence. Jan 5 (1), 57\u201365. https:\/\/doi.org\/10.4161\/viru.26514 (2014).","journal-title":"Jan"},{"key":"26183_CR5","doi-asserted-by":"publisher","unstructured":"Lion, C., Escande, F. & Burdin, J. C. Capnocytophaga canimorsus infections in human: Review of the literature and cases report, European Journal of Epidemiology. 12(5), 521\u2013533. https:\/\/doi.org\/10.1007\/BF00144007 (Oct. 1996).","DOI":"10.1007\/BF00144007"},{"key":"26183_CR6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ijid.2017.03.005","volume":"58","author":"J Rannikko","year":"2017","unstructured":"Rannikko, J., Syrj\u00e4nen, J., Seiskari, T., Aittoniemi, J. & Huttunen, R. Sepsis-related mortality in 497 cases with blood culture-positive sepsis in an emergency department. Int. J. Infect. Dis. 58, 52\u201357. https:\/\/doi.org\/10.1016\/j.ijid.2017.03.005 (2017).","journal-title":"Int. J. Infect. Dis."},{"issue":"5","key":"26183_CR7","doi-asserted-by":"publisher","first-page":"R291","DOI":"10.1186\/cc2893","volume":"8","author":"MD Williams","year":"2004","unstructured":"Williams, M. D. et al. Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care. Crit. Care. 8 (5), R291. https:\/\/doi.org\/10.1186\/cc2893 (2004).","journal-title":"Crit. Care"},{"key":"26183_CR8","doi-asserted-by":"publisher","unstructured":"Kany, S., Vollrath, J. T. & Relja, B. Cytokines in Inflammatory Disease, IJMS. 20(23), 6008. https:\/\/doi.org\/10.3390\/ijms20236008 (Nov. 2019).","DOI":"10.3390\/ijms20236008"},{"key":"26183_CR9","doi-asserted-by":"publisher","unstructured":"Lawrence, T., Willoughby, D. A. & Gilroy, D. W. Anti-inflammatory lipid mediators and insights into the resolution of inflammation, Nat Rev Immunol. 2(10), 787\u2013795. https:\/\/doi.org\/10.1038\/nri915 (Oct. 2002).","DOI":"10.1038\/nri915"},{"key":"26183_CR10","doi-asserted-by":"publisher","unstructured":"Fredriksson, S. et al. Multiplexed protein detection by proximity ligation for cancer biomarker validation, Nat Methods. 4(4), 327\u2013329. https:\/\/doi.org\/10.1038\/nmeth1020 (Apr. 2007).","DOI":"10.1038\/nmeth1020"},{"key":"26183_CR11","doi-asserted-by":"publisher","unstructured":"Van Der Vaart, T. W. et al. All-Cause and Infection-Related mortality in Staphylococcus aureus Bacteremia, a multicenter prospective cohort study. Open. Forum Infect. Dis. 9 (12), ofac653. https:\/\/doi.org\/10.1093\/ofid\/ofac653 (Dec. 2022).","DOI":"10.1093\/ofid\/ofac653"},{"issue":"5","key":"26183_CR12","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/joim.12946","volume":"286","author":"J Rannikko","year":"2019","unstructured":"Rannikko, J. et al. Reduced plasma PCSK9 response in patients with bacteraemia is associated with mortality. J. Intern. Med. 286 (5), 553\u2013561. https:\/\/doi.org\/10.1111\/joim.12946 (2019).","journal-title":"J. Intern. Med."},{"issue":"4","key":"26183_CR13","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/joim.12766","volume":"284","author":"J Rannikko","year":"2018","unstructured":"Rannikko, J. et al. Plasma cell-free DNA and qSOFA score predict 7-day mortality in 481 emergency department bacteraemia patients. J. Intern. Med. 284 (4), 418\u2013426. https:\/\/doi.org\/10.1111\/joim.12766 (2018).","journal-title":"J. Intern. Med."},{"key":"26183_CR14","unstructured":"Olink\u00ae Target 96 Inflammation Protein assay list. [Online]. Available: https:\/\/olink.com\/products\/olink-target-96"},{"key":"26183_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-1-60761-175-2_7","volume-title":"Protein Networks and Pathway Analysis","author":"H Mi","year":"2009","unstructured":"Mi, H. & Thomas, P. PANTHER pathway: an Ontology-Based pathway database coupled with data analysis tools. In Protein Networks and Pathway Analysis (eds Nikolsky, Y. & Bryant, J.) 123\u2013140 (Humana, 2009). https:\/\/doi.org\/10.1007\/978-1-60761-175-2_7."},{"key":"26183_CR16","doi-asserted-by":"publisher","unstructured":"Jassal, B. et al. Nov., The reactome pathway knowledgebase, Nucleic Acids Research. gkz1031. https:\/\/doi.org\/10.1093\/nar\/gkz1031 (2019).","DOI":"10.1093\/nar\/gkz1031"},{"key":"26183_CR17","doi-asserted-by":"publisher","unstructured":"Heberle, H., Meirelles, G. V., da Silva, F. R., Telles, G. P. & Minghim, R. InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams. BMC Bioinform. 16 (1), 169. https:\/\/doi.org\/10.1186\/s12859-015-0611-3 (May 2015).","DOI":"10.1186\/s12859-015-0611-3"},{"key":"26183_CR18","doi-asserted-by":"publisher","unstructured":"Nakamura, T. & Mizuno, S. The discovery of Hepatocyte Growth Factor (HGF) and its significance for cell biology, life sciences and clinical medicine, Proc. Jpn. Acad., Ser. B. 86(6), 588\u2013610. https:\/\/doi.org\/10.2183\/pjab.86.588 (2010).","DOI":"10.2183\/pjab.86.588"},{"key":"26183_CR19","doi-asserted-by":"publisher","unstructured":"Nayeri, F. et al. High Serum Hepatocyte Growth Factor Levels in the Acute Stage of Community-acquired Infectious Diseases, Scandinavian Journal of Infectious Diseases. 34(2), 127\u2013130. https:\/\/doi.org\/10.1080\/00365540110077236 (Jan. 2002).","DOI":"10.1080\/00365540110077236"},{"issue":"2","key":"26183_CR20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s10156-004-0301-Y","volume":"10","author":"K Sekine","year":"2004","unstructured":"Sekine, K., Fujishima, S. & Aikawa, N. Plasma hepatocyte growth factor is increased in early-phase sepsis. J. Infect. Chemother. 10 (2), 110\u2013114. https:\/\/doi.org\/10.1007\/s10156-004-0301-Y (2004).","journal-title":"J. Infect. Chemother."},{"key":"26183_CR21","doi-asserted-by":"publisher","unstructured":"Peng, F. et al. Mar., Prognostic Significance of Plasma Hepatocyte Growth Factor in Sepsis, J Intensive Care Med. 37(3), 352\u2013358.  https:\/\/doi.org\/10.1177\/0885066621993423 (2022).","DOI":"10.1177\/0885066621993423"},{"key":"26183_CR22","doi-asserted-by":"publisher","unstructured":"Hotchkiss, R. S., Monneret, G. & Payen, D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy, Nat Rev Immunol. 13(12), 862\u2013874.https:\/\/doi.org\/10.1038\/nri3552 (Dec. 2013).","DOI":"10.1038\/nri3552"},{"key":"26183_CR23","doi-asserted-by":"publisher","unstructured":"Toliver-Kinsky, T. E., Cui, W., Murphey, E. D., Lin, C. & Sherwood, E. R. Enhancement of dendritic cell production by Fms-Like tyrosine Kinase-3 ligand increases the resistance of mice to a burn wound infection. J. Immunol. 174 (1), 404\u2013410. https:\/\/doi.org\/10.4049\/jimmunol.174.1.404 (Jan. 2005).","DOI":"10.4049\/jimmunol.174.1.404"},{"key":"26183_CR24","doi-asserted-by":"publisher","unstructured":"Guermonprez, P. et al. Jun., Inflammatory Flt3l is essential to mobilize dendritic cells and for T cell responses during Plasmodium infection, Nat Med. 19(6), 730\u2013738. https:\/\/doi.org\/10.1038\/nm.3197 (2013).","DOI":"10.1038\/nm.3197"},{"key":"26183_CR25","doi-asserted-by":"publisher","unstructured":"Eidenschenk, C. et al. May., Flt3 permits survival during infection by rendering dendritic cells competent to activate NK cells, Proc. Natl. Acad. Sci. U.S.A., 107(21), 9759\u20139764. https:\/\/doi.org\/10.1073\/pnas.1005186107 (2010).","DOI":"10.1073\/pnas.1005186107"},{"key":"26183_CR26","doi-asserted-by":"publisher","unstructured":"Swedik, S., Madola, A. & Levine, A. IL-17\u00a0C in human mucosal immunity: More than just a middle child. Cytokine 146, 155641. https:\/\/doi.org\/10.1016\/j.cyto.2021.155641 (Oct. 2021).","DOI":"10.1016\/j.cyto.2021.155641"},{"key":"26183_CR27","doi-asserted-by":"publisher","unstructured":"Ramirez-Carrozzi, V. et al. Dec., IL-17\u00a0C regulates the innate immune function of epithelial cells in an autocrine manner, Nat Immunol. 12(12), 1159\u20131166.  https:\/\/doi.org\/10.1038\/ni.2156 (2011).","DOI":"10.1038\/ni.2156"},{"key":"26183_CR28","doi-asserted-by":"publisher","unstructured":"Larsen, I. K., Pedersen, G. & Sch\u00f8nheyder, H. C. Bacteraemia with an unknown focus: is the focus de facto absent or merely unreported? A one-year hospital-based cohort study. APMIS 119, 4\u20135. https:\/\/doi.org\/10.1111\/j.1600-0463.2011.02727.x (Apr. 2011).","DOI":"10.1111\/j.1600-0463.2011.02727.x"},{"key":"26183_CR29","doi-asserted-by":"publisher","unstructured":"Leibovici, L., Konisberger, H., Pitlik, S. D., Samra, Z. & Drucker, M. Bacteremia and fungemia of unknown origin in adults. Clin. Infect. Dis. 14 (2), 436\u2013443. https:\/\/doi.org\/10.1093\/clinids\/14.2.436 (Feb. 1992).","DOI":"10.1093\/clinids\/14.2.436"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26183-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26183-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26183-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T13:13:53Z","timestamp":1764162833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26183-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["26183"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-26183-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"17 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Markus Ojanen: No conflicts of interest,Tapio Seiskari: No conflicts of interest,Janne Aittoniemi: A member of the Nordic Infucare AB Finnish advisory board,Heini Huhtala: No conflicts of interest,Reetta Huttunen: No conflicts of interest,Jaana Syrj\u00e4nen: No conflicts of interest, Ilkka Junttila: No conflicts of interest,Marko Pesu: No conflicts of interest,Juha Rannikko: International congress attendance fee from Gilead and Pfizer.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Potential conflicts of interest"}}],"article-number":"42134"}}